Different basic fibroblast growth factor and fibroblast growth factor-antisense expression in eutopic endometrial stromal cells derived from women with and without endometriosis

The Journal of Clinical Endocrinology and Metabolism
A MihalichA M Di Blasio

Abstract

In all species studied, the basic fibroblast growth factor (bFGF) gene is transcribed into multiple mRNAs, one of which is an antisense RNA (1B FGF-AS) probably involved in regulating the stability of the sense transcript. In this study we investigated whether the regulatory mechanisms of bFGF expression might be altered in endometrial stromal cells derived from women with endometriosis. bFGF and 1B FGF-AS mRNA levels were quantified in primary cultures of eutopic endometrial stromal cells derived from 29 women without endometriosis and 24 patients affected by the disease. When the data were analyzed according to the phase of the menstrual cycle, endometrial stromal cells derived from patients in the late proliferative phase showed significantly higher bFGF mRNA values and significantly lower 1B FGF-AS mRNA levels compared with control samples. Furthermore, the mean bFGF/1B FGF-AS mRNA ratio was significantly higher in endometrial stromal cells derived from patients compared with that in controls (mean +/- SEM, 2.31 +/- 0,55 and 0.77 +/- 0.14, respectively; P = 0.009). Moreover, for bFGF expression the differences existing at the mRNA level were maintained at the protein level. These findings support the hypothesis that 1B FGF-...Continue Reading

Citations

Jun 15, 2007·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Shuo Cheng ZhangPaul R Murphy
Apr 23, 2004·Trends in Biochemical Sciences·Giovanni LavorgnaGiorgio Casari
Dec 5, 2006·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Cai JingtingPeng Lixiu
Apr 1, 2009·Journal of Cellular Physiology·Stéphane PetitSylvie Babajko
Jun 21, 2013·Oral Diseases·P PerezI Alevizos
Feb 1, 2005·Computational Biology and Chemistry·Izabela MakalowskaWojciech Makalowski
Feb 24, 2005·Leukemia Research·Mark Baguma-NibashekaPaul R Murphy
Nov 10, 2004·Fertility and Sterility·Sachiko MatsuzakiGerard Mage
May 26, 2004·Best Practice & Research. Clinical Obstetrics & Gynaecology·Paola ViganòPaolo Vercellini
Jan 16, 2015·Biology of Reproduction·Laila F Jerman, Alison J Hey-Cunningham
Apr 21, 2016·The Cochrane Database of Systematic Reviews·Devashana GuptaVicki Nisenblat
Mar 4, 2010·Molecular Endocrinology·Leigh-Ann MacFarlanePaul R Murphy
Feb 21, 2014·Molecular Endocrinology·Lori A McEachern, Paul R Murphy
Oct 14, 2009·International Journal of Immunopathology and Pharmacology·D MarzioniR Montironi
Jul 29, 2019·Cellular and Molecular Life Sciences : CMLS·Shuangbo KongJinhua Lu
Nov 26, 2020·Scientific Reports·Norbert MoldovánZsolt Boldogkői
Nov 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christie BarclayAlan G Casson
May 26, 2021·Obstetrical & Gynecological Survey·Nikolaos ThanatsisApostolos Kaponis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.